Helicobacter pylori strain B25

Helicobacter pylori strain B25 is a Gram-negative, microaerophilic bacterium that exhibits a spirilla shape and possesses flagella, allowing for mobility. It typically exists as single cells and is classified as bioactively free-living, although it is primarily host-associated, with Homo sapiens being a major host along with various other species such as Gallus gallus, Aves, Primates, Mammalia, Amoeba, Rodentia, and Cricetinae. This strain thrives optimally at 37°C, indicating its mesophilic nature. It has a unique cellular structure, characterized by two membranes and a single replicon. The pathogenicity of H. pylori strain B25 is particularly concerning in humans, as it is linked to a range of severe health effects, including chronic gastric inflammation, peptic ulcer disease, and various forms of gastric cancer such as adenocarcinoma and mucosa-associated lymphoid tissue lymphoma. Symptoms can include gastritis, GERD, functional dyspepsia, and other gastrointestinal diseases. The strain's ability to induce chronic mucosal inflammatory responses can lead to long-term health issues, including atrophic gastritis and intestinal metaplasia, which are precursors to gastric carcinoma. Given the extensive health implications associated with H. pylori strain B25, its role in the human gastrointestinal tract underscores the importance of studying this bacterium for understanding its pathogenic mechanisms and potential therapeutic targets.